Statement of Principles concerning malignant neoplasm of unknown primary site (Balance of Probabilities) (No. 104 of 2022) (Cth)

Statement of Principles concerning MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE (Balance of Probabilities) (No. 104 of 2022) The Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(3) of the Veterans' Entitlements Act 1986.

Dated 21 October 2022

The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:

Professor Terence Campbell AM Chairperson

Contents 1 Name 2 Commencement 3 Authority 4 Repeal 5 Application 6 Definitions 7 Kind of injury, disease or death to which this Statement of Principles relates 8 Basis for determining the factors 9 Factors that must exist 10 Relationship to service 11 Factors referring to an injury or disease covered by another Statement of Principles Schedule 1 - Dictionary 1 Definitions

1 Name This is the Statement of Principles concerning malignant neoplasm of unknown primary site (Balance of Probabilities) (No. 104 of 2022). 2 Commencement This instrument commences on 21 November 2022. 3 Authority This instrument is made under subsection 196B(3) of the Veterans' Entitlements Act 1986. 4 Repeal The Statement of Principles concerning malignant neoplasm of unknown primary site No. 81 of 2014 (Federal Register of Legislation No. F2014L01143) made under subsections 196B(3) and (8) of the VEA is repealed. 5 Application This instrument applies to a claim to which section 120B of the VEA or section 339 of the Military Rehabilitation and Compensation Act 2004 applies. 6 Definitions The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument. 7 Kind of injury, disease or death to which this Statement of Principles relates (1) This Statement of Principles is about malignant neoplasm of unknown primary site and death from malignant neoplasm of unknown primary site. Meaning of malignant neoplasm of unknown primary site (2) For the purposes of this Statement of Principles, malignant neoplasm of unknown primary site: (a) means a histologically confirmed metastatic malignant neoplasm for which the primary tumour site cannot be identified after a complete history, physical examination and appropriate diagnostic investigations have been carried out; and (b) excludes: (i) haematolymphoid tumours (including non-Hodgkin lymphoma and Hodgkin's lymphoma); (ii) malignant melanoma; and (iii) mesenchymal tumours (including soft tissue sarcoma). Note: Histological types of malignant neoplasm of unknown primary site include adenocarcinomas, squamous cell carcinomas, neuroendocrine tumours and poorly differentiated or undifferentiated neoplasms. (3) While malignant neoplasm of unknown primary site attracts ICD‑10‑AM code C80, in applying this Statement of Principles the meaning of malignant neoplasm of unknown primary site is that given in subsection (2). (4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4. Death from malignant neoplasm of unknown primary site (5) For the purposes of this Statement of Principles, malignant neoplasm of unknown primary site, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's malignant neoplasm of unknown primary site. Note: terminal event is defined in the Schedule 1 – Dictionary. 8 Basis for determining the factors On the sound medical‑scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that malignant neoplasm of unknown primary site and death from malignant neoplasm of unknown primary site can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA. Note: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary. 9 Factors that must exist At least one of the following factors must exist before it can be said that, on the balance of probabilities, malignant neoplasm of unknown primary site or death from malignant neoplasm of unknown primary site is connected with the circumstances of a person's relevant service: (1) having smoked tobacco products: (a) in an amount of at least 20 pack-years before the clinical onset of malignant neoplasm of unknown primary site; and (b) commencing at least 5 years before the clinical onset of malignant neoplasm of unknown primary site; and if smoking has ceased before the clinical onset of malignant neoplasm of unknown primary site, then that onset occurred within 20 years of cessation; Note: one pack-year is defined in the Schedule 1 - Dictionary. (2) consuming alcohol: (a) in an amount of at least 200 kilograms before the clinical onset of malignant neoplasm of unknown primary site; and (b) where consumption of alcohol commenced at least 5 years before the clinical onset of malignant neoplasm of unknown primary site; and if consumption of alcohol has ceased before the clinical onset of malignant neoplasm of unknown primary site, then that onset occurred within 40 years of cessation; Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink. (3) having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to at least one location in the body, at least 5 years before the clinical onset of malignant neoplasm of unknown primary site; Note: cumulative equivalent dose is defined in the Schedule 1 – Dictionary. (4) for squamous cell carcinoma of unknown primary site of the head and neck only, having infection of the epithelium of the: (a) oral cavity; (b) oropharynx; or (c) larynx; with human papillomavirus type 16 or 18 before the clinical onset of malignant neoplasm of unknown primary site; Note: squamous cell carcinoma of unknown primary site of the head and neck is defined in the Schedule 1 - Dictionary. (5) for squamous cell carcinoma of unknown primary site involving the inguinal lymph nodes only, having infection of the epithelium of the: (a) anus or anal canal; (b) cervix; (c) penis; (d) vagina; or (e) vulva; with a specified human papillomavirus before the clinical onset of malignant neoplasm of unknown primary site; Note: specified human papillomavirus is defined in the Schedule 1 - Dictionary. (6) for squamous cell carcinoma of unknown primary site of the head and neck only, having infection with Epstein-Barr virus before the clinical onset of malignant neoplasm of unknown primary site; Note: squamous cell carcinoma of unknown primary site of the head and neck is defined in the Schedule 1 - Dictionary. (7) inability to obtain appropriate clinical management for malignant neoplasm of unknown primary site. 10 Relationship to service (1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person. (2) The factor set out in subsection 9(7) applies only to material contribution to, or aggravation of, malignant neoplasm of unknown primary site where the person's malignant neoplasm of unknown primary site was suffered or contracted before or during (but did not arise out of) the person's relevant service. 11 Factors referring to an injury or disease covered by another Statement of Principles In this Statement of Principles: (1) if a factor referred to in section 9 applies in relation to a person; and (2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(3) of the VEA; then the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.